LEXICON PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2025-03-07
- LEXICON PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2024 was $0.00.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was $0.00.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was -$3.00K.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was -$49.00K, a 106.93% decline from fiscal 2020.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-07 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-07 |
| 2022-12-31 | -$3.00K 10-K · filed 2025-03-07 |
| 2021-12-31 | -$49.00K 10-K · filed 2024-03-25 |
| 2020-12-31 | $707.00K 10-K · filed 2023-03-03 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-10 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-12 |
| 2017-12-31 | -$3.00K 10-K · filed 2020-03-12 |
| 2016-12-31 | -$16.00K 10-K · filed 2019-03-15 |
| 2015-12-31 | $47.00K 10-K · filed 2018-03-01 |
| 2014-12-31 | $1.63M 10-K · filed 2017-03-06 |
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 |
| 2012-12-31 | $0.00 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |